Prox1-CreERT2 Mouse

Random Transgenic

Prox1-CreERT2 Random Transgenic Mouse Model
Inquire
CALL: 888.822.6642 + 45 70 23 04 05 (EUROPE and DENMARK) +49 214 50 68 023 (GERMANY)
EZcohort® Models
The easiest way to acquire and breed cryopreserved GEMs
LEARN MORE
This model is available for immediate cryorecovery.

C57BL6 Background

  • Model #
  • Genotype
  • Nomenclature
  • 14092
    B6.Cg-Tg(Prox1-cre/ERT2)1Tmak

  • An inducible cre deleter under the control of the prospero homeobox 1 (Prox1) promoter.
  • Cre recombination is inducible via administration of tamoxifen.
  • Allows specific and temporally controlled cre-loxP recombination (gene inactivation/activation) in Prox1-expressing tissues, including lymphatic endothelia.
  • Efficient recombination is observed during all developmental stages (embryonic, postnatal) and in adults.

    Genetic Background:

    C57BL6

    Origin:

    The Prxo1-creERT2 mouse was developed in the laboratory of Taija Makinen at the London Research Institute. A cDNA encoding tamoxifen inducible Cre recombinase (CreERT2) followed by SV40 polyadenylation signal was introduced into the start codon of Prox1 in BAC clone RP23-190F21 using homologous recombination in bacteria. Founder lines were backcrossed to C57BL/6. Taconic received embryos from CRT in 2015.


    Species:

    Mouse

    Initial Publication:

    Bazigou et al. 2011. Genes regulating lymphangiogenesis control venous valve formation and maintenance in mice. J Clin Invest. Aug 1; 121(8): 2984–2992.


    • To purchase this EZcohort model, sign the Terms of Sale (choose from the list below) and email it directly to legal@taconic.com:

    This model is sold under terms which grant perpetual use rights.
    Close

    Welcome! Tell us a little about yourself